FDA-Drug2026-07-29Class IIIMISBRANDING
Asclemed Lidolog Kit lidocaine injection recalled for barcode labeling defect
What this means
Asclemed USA Inc. is recalling Lidolog Kit, which contains lidocaine injection, because the label wrap covers the barcode, making it difficult to scan. This labeling defect affects 18 kits distributed in Tennessee.
- Check your inventory for Lidolog Kit lot 070126X1 with expiration 12/31/2027.
- Do not use affected kits if the barcode cannot be scanned clearly.
- Contact your supplier or Asclemed USA Inc. for return or replacement instructions.
The agency's original wording
Hazard
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Intended for
Adults
Illnesses reported
None reported
Sold states
Within U.S. - Tennessee
Affected count
18 kits
Manufactured in
379 Van Ness Ave Ste 1403, N/A, Torrance, CA, United States
Products
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0713-2026More Asclemed recalls
- FDA-Drug2026-07-08Asclemed Lidocaine HCl Injection recalled for lack of sterility assurance
- FDA-Drug2026-07-08Accucaine lidocaine injection recalled for lack of sterility assurance
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.